Headshot of Katherine Jia
Profiles

Katherine Min Jia

Postdoctoral Associate - Boston University School of Public Health

(617) 358-2422
kjia@bu.edu
Crosstown Center
View Full Profile at BUMC

Biography

I am a Postdoctoral Associate at the Boston University School of Public Health. I am an infectious disease epidemiologist who develops and applies causal inference methods to evaluate the effectiveness of pharmaceuticals and to quantify the impact of health policies. My research focuses on infectious disease modeling, empirical studies of vaccines and antiviral treatments, and strategies to optimize infectious disease control programs. I also have experience collaborating with state, federal, and international organizations.

I received my PhD in Epidemiology and MS in Biostatistics from Harvard University in 2025. I also hold an MS in Epidemiology from Imperial College London (2020) and a BS in Public Health with a minor in Mathematics from The Chinese University of Hong Kong (2019).

Publications

  • Published on 7/1/2026

    Jia KM, Boyer CB, Bilinski A, Lipsitch M. Defining and Estimating Outcomes Directly Averted by a Vaccination Program when Rollout Occurs Over Time. Epidemiology. 2026; 37(4):408-416.
  • Published on 1/19/2026

    Jia KM, Boyer CB, Bilinski A, Lipsitch M. Defining and Estimating Outcomes Directly Averted by a Vaccination Program when Rollout Occurs Over Time. Epidemiology. 2026 Jul 01; 37(4):408-416. PMID: 41570185.

     Read At: PubMed
  • Published on 12/21/2025

    Guo Z, Wei Y, Lin G, Jia KM, Boyer C, Wang H, Li C, Hung CT, Yam CHK, Chow TY, Zhao S, Li K, Yang A, Mok CKP, Hui DS, Yeoh EK, Chong KC. Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study. Nat Commun. 2025 Dec 21; 17(1):1031. PMID: 41423550.

     Read At: PubMed
  • Published on 11/4/2025

    Dankwa EA, Cavalli L, Balasubramanian R, Can MH, Cui H, Jia KM, Li Y, Ofori SK, Swartwood NA, Wade CG, Buckee CO, Imai-Eaton JW, Menzies NA. Calibration of transmission-dynamic infectious disease models: A scoping review and reporting framework. PLoS Comput Biol. 2025 Nov; 21(11):e1013647. PMID: 41187204.

     Read At: PubMed
  • Published on 7/28/2025

    Chong KC, Wei Y, Jia KM, Boyer C, Lin G, Wang H, Li C, Hung CT, Jiang X, Yam CHK, Chow TY, Wang Y, Zhao S, Li K, Yang A, Mok CKP, Hui DS, Yeoh EK, Guo Z. SARS-CoV-2 rebound and post-acute mortality and hospitalization among patients admitted with COVID-19: cohort study. Nat Commun. 2025 Jul 28; 16(1):6924. PMID: 40721474.

     Read At: PubMed
  • Published on 3/4/2025

    Wei Y, Boyer C, Jia KM, Lin G, Wang H, Li C, Hung CT, Jiang X, Yam CHK, Chow TY, Wang Y, Zhao S, Guo Z, Li K, Yang A, Mok CKP, Hui DSC, Chong KC, Yeoh EK. Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigation. Emerg Microbes Infect. 2025 Dec; 14(1):2469648. PMID: 39964106.

     Read At: PubMed
  • Published on 2/1/2025

    Lin G, Wei Y, Wang H, Boyer C, Jia KM, Hung CT, Jiang X, Li C, Yam CHK, Chow TY, Wang Y, Zhao S, Guo Z, Li K, Yang A, Mok CKP, Hui DSC, Chong KC, Yeoh EK. Association of nirmatrelvir/ritonavir with post-acute sequelae and mortality among immunocompromised patients with COVID-19: a real-world retrospective cohort study. The Lancet Rheumatology. 2025; 7(2):e108-117.
  • Published on 1/24/2025

    Jia KM, Boyer CB, Wallinga J, Lipsitch M. Causal Estimands for Analyses of Averted and Avertible Outcomes due to Infectious Disease Interventions. Epidemiology. 2025 May 01; 36(3):363-373. PMID: 39855261.

     Read At: PubMed
  • Published on 11/8/2024

    Lin G, Wei Y, Wang H, Boyer C, Jia KM, Hung CT, Jiang X, Li C, Yam CHK, Chow TY, Wang Y, Zhao S, Guo Z, Li K, Yang A, Mok CKP, Hui DSC, Chong KC, Yeoh EK. Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality among patients who are immunocompromised with COVID-19 in Hong Kong: a retrospective cohort study. Lancet Rheumatol. 2025 Feb; 7(2):e108-e117. PMID: 39527967.

     Read At: PubMed
  • Published on 11/4/2024

    Wang H, Wei Y, Lin G, Boyer C, Jia KM, Hung CT, Jiang X, Li C, Yam CHK, Chow TY, Wang Y, Zhao S, Guo Z, Li K, Yang A, Mok CKP, Hui DSC, Chong KC, Yeoh EK. COVID-19 vaccination modified the effect of nirmatrelvir-ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study. Emerg Microbes Infect. 2024 Dec; 13(1):2421397. PMID: 39497519.

     Read At: PubMed

View 22 more publications:View Full Profile at BUMC

View all profiles